RBC Capital Maintains Outperform Rating on Xylem, Cuts Target to $135
RBC Capital maintained its Outperform rating on Xylem and cut its price target to $135 per share from $164.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.